BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4107763)

  • 1. A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies.
    Lichtenstein LM; Norman PS; Winkenwerder WL
    Ann Intern Med; 1971 Nov; 75(5):663-71. PubMed ID: 4107763
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever.
    Lichtenstein LM; Norman PS; Winkenwerder WL
    Am J Med; 1968 Apr; 44(4):514-24. PubMed ID: 4171086
    [No Abstract]   [Full Text] [Related]  

  • 3. Maintenance immunotherapy in ragweed hay fever. Booster injections at six week intervals.
    Norman PS; Winkenwerder WL; Lichtenstein LM
    J Allergy; 1971 May; 47(5):273-82. PubMed ID: 4102487
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of immunotherapy.
    Norman PS
    Allergy; 1978 Apr; 33(2):62-70. PubMed ID: 80138
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of pollinosis in children: investigation of the immunologic basis of clinical improvement.
    Sadan N; Rhyne MB; Mellits ED; Goldstein EO; Levy DA; Lichtenstein LM
    N Engl J Med; 1969 Mar; 280(12):623-7. PubMed ID: 4180015
    [No Abstract]   [Full Text] [Related]  

  • 6. Trials of alum-precipitated pollen extracts in the treatment of hay fever.
    Norman PS; Winkenwerder WL; Lichtenstein LM
    J Allergy Clin Immunol; 1972 Jul; 50(1):31-44. PubMed ID: 4113507
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new desensitization agent in the treatment of ragweed-induced seasonal allergic rhinitis (hay fever) in children: MRTA (modified ragweed tyrosine adsorbate)].
    Weisnagel J
    Union Med Can; 1979 Jun; 108(6):685-90. PubMed ID: 116408
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy.
    Brunet C; Bédard PM; Lavoie A; Jobin M; Hébert J
    J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):87-94. PubMed ID: 1370511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunologic studies of ragweed immunotherapy.
    Melam H; Pruzansky J; Patterson R; Singer S
    J Allergy; 1971 May; 47(5):262-72. PubMed ID: 4102486
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever.
    Van Metre TE; Adkinson NF; Amodio FJ; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL; Sobotka AK; Valentine MD
    J Allergy Clin Immunol; 1980 Dec; 66(6):500-13. PubMed ID: 6159384
    [No Abstract]   [Full Text] [Related]  

  • 12. Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.
    Yunginger JW; Gleich GJ
    J Clin Invest; 1973 May; 52(5):1268-75. PubMed ID: 4735589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled evaluations of repository therapy in ragweed hay fever.
    Norman PS; Winkenwerder WL; D'Lugoff BC; Tignall J
    J Allergy; 1967 Feb; 39(2):82-92. PubMed ID: 5340238
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies in pollen allergy. 3. The relationship between blocking antibody levels and symptomatic relief following hyposensitisation with allpyral in hay fever subjects.
    Starr MS; Weinstock M
    Int Arch Allergy Appl Immunol; 1970; 38(5):514-21. PubMed ID: 4191851
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos.
    Norman PS; Winkenwerder WL; Lichtenstein LM
    J Allergy; 1968 Aug; 42(2):93-108. PubMed ID: 4873833
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic and cellular changes accompanying the therapy of pollen allergy.
    Levy DA; Lichtenstein LM; Goldstein EO; Ishizaka K
    J Clin Invest; 1971 Feb; 50(2):360-9. PubMed ID: 4099843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects.
    D'Souza MF; Pepys J; Wells ID; Tai E; Palmer F; Overell BG; McGrath IT; Megson M
    Clin Allergy; 1973 Jun; 3(2):177-93. PubMed ID: 4131252
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukocyte histamine release and humoral changes during oral and subcutaneous hyposensitization of grass pollen allergic children.
    Wahn U; Maasch HJ; Geissler W
    Helv Paediatr Acta; 1984 May; 39(2):137-44. PubMed ID: 6085730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is desensitization' for ragweed hay fever immunologically specific?
    Lichtenstein LM; Levy DA
    Int Arch Allergy Appl Immunol; 1972; 42(4):615-26. PubMed ID: 4113011
    [No Abstract]   [Full Text] [Related]  

  • 20. Ragweed pollen: a review.
    Goldfarb AR
    J Asthma Res; 1972 Mar; 9(3):139-52. PubMed ID: 4116452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.